CURRENT 2018 Attendees

DOWNLOAD THE BROCHURE
REGISTER NOW

2018 Event Partners

CURRENT 2018 attendING COMPANIES INCLUDE

Please note: A company that is not affiliated with Biotech and Money Ltd. is contacting attendees of our event offering to sell the 2018 Biotech and Money / Medtech and Money attendee list. They are not operating with our approval. Biotech and Money, have not and will not share any data with this company or any other outside party.

02H Ventures Industrifonden
4Bio Capital InflaRx GmbH
4D Pharma InHealth Ventures
4SC INKEF Capital
A2VL Inmedix Inc
Abingworth Innogest
Ablynx Inserm Transfert
Absail Capital Instinctif
Accelerace Interax Biotech
Acceleris Capital Interceptin
Accelmed Inventages
Active Needle Investment fund
Addex Therapeutics IO Biotech
AdRem Capital IP Group
Advent France Biotechnology IPF Partners
Advent Life Sciences IPF Partners
Aglaris ISIF
Alacrita Ivaldi Capital
Albion Capital J O Hambro Capital Management
Albion Technology & General VCT JAG Shaw Baker
Alderley Park Ventures Julz & Co.
Allen & Overy Kammeradvokaten
Alsa Holdings Karolinska Development
Amadeus Capital Partners Keiretsu Forum
Angel Investor Kiadis
Antabio King's College London
Apeiron Biologics AG Kinled Holding Ltd
Arecor Kreos Capital
Arix Bioscience Kurma Partners
Arterial Capital Management Laurel Ventures
Arthurian Life Sciences Leerink
Artios Pharma LifeArc
Asarina Pharma LIG Biowise
Astraveus Longevity Capital Partners
AstraZeneca Longwall Ventures
Atelix Ltd Lonza
Atlantic Bridge Magle Chemoswed
Atriva Therapeutics Mangogen
AurorA-TT Marks & Clerk
Auspherix Masselos Family Office
Avego Healthcare Capital McLaren Applied Technologies
AVM Biotech Medherant
Balmes Transplantation Medicxi
Baxter Medivir
Beaufort Sciences Medlumics
Belsize Asset Management MedNous
Bioartic Medtech Insight 
BioGeneration Ventures Medtronic
BioPharm Insight MedXelerator
BioProtect Meneldor
Biosana Pharma Mercia Technologies
Bioscience Managers Merck
BioSeed Capital Merck Ventures BV
Biosignatures Limited MetaLinear
BioTissue MISSION Therapeutics
Biovotion MOLOGEN AG
Bloomberg Intelligence Momentum Biotech
Blueprint Genetics Monta Biosciences
BNY Mellon Montagu Asset Management
Boehringer Ingelheim Morphosys
Bone Support AB MSD
Bone Therapeutics MSIF
Boston Scientific MTIP
Boston Scientific Ventures Mubadala
BPI France MXC Capital
Brainwave Bank N+1 Singer
Braster NASDAQ
British Expats in Life Sciences NCL Technology Ventures
BROTHERS & Partners Europe NeoMed
Brown Rudnick NetScientific
Calcivis New Science Fund
Cambridge Angels Newable
Cambridge Enterprise Newcastle Gateshead Initiative
Cambridge Innovation Capital Norgine
Cambridge Medical Robotics Ltd North-East Healthcare
Cambridge Medtech Novo Seeds
Camd Novo Ventures
Cancer Research Technology NOXXON Pharma
Cantargia NW Ventures
Capital Cell NY Consulting
Carmell Therapeutics Oisin Biotechnologies Inc
Carnegie Olympus Europa
Catapult Ventures OMNES Capital
Celgene Oncogenx
Cell & Gene Therapy Catapult Oncology Venture
Cerescom Oncopeptides AB
Chronos Therapeutics OrbiMed
Circassia Orca Therapeutics BV
Clinigen ORI CAPITAL
Clubb Capital Ostara Biomedical
CN Bio Innovations Owlstone Medical Ltd
CO.DON AG Oxford AHSN
Cocoon Networks Oxford BioMedica
ColeCap Oxford Technology
Confo Therapeutics Oxford University Innovation Ltd.
Consilium Communications Oxon
Cooley Oxstem
Coulter Partners Panakes
Covington Panmure Gordon 
CRB Inverbío Paul Capital
Crescendo Biologics PCI Biotech
Crispr Therapeutics Peppermint Venture Partners GmbH
Crossroad Biotech Perora
Curam Capital PhagoMed
DA VOLTERRA PharmaStandard Ventures
DDFV Pharmaventures
Debere Partners Pharmstandard Ventures
Deepbridge Capital PI Trading
Destiny Pharma Principia SGR
Diamond Biopharm Private Investor
Digital Catapult  Probiodrug AG
Downing QuantuMDx
Droia NV Rainbow Seed Fund
DSM Ventures RBC Capital
Duke Street Re-Pharm
Dyadic Reapplix
Dynasty Biotechnology RedEye
e-Therapeutics ReNeuron
Earlybird Venture Capital Renovos
Edmond de Rothschild Investment Partners RMI Partners
Eli Lilly and Company Rosetta Capital
Enesi Pharma Limited Rothschild
Enterprise Ireland RYSE Asset Management
Entrust Life Sciences Scancell Holdings
Entrust People SCRIP Pharma Intelligence
EP Vantage Selvita SA
Epi-Endo Pharmaceuticals Senzime
EpimAb Biotherapeutics Seroba Life Sciences
Esperante Ventures SGRF
Eurocine Vaccines AB Siemens Healthineers
European Investment Fund Silence Therapeutics
Excalibur Group Sixth Element Capital
Exonate SJB Technical Recruitment
EY Sofinnova Partners
F-Prime Capital SOM Biotech
F-star Biotechnology SPARK Impact
Femeda SPL Pharma
Fiagon SR-One
Financial Times Stent Tek
Flagship Ventures Storm Therapeutics Ltd
Fountain Health Partners Sugacoll
FreeMind Summit plc
Fresenius Medical Care Ventures GmbH Sunstone Capital
Future Care Capital SV Health Investors
Galapagos NV Syncona Partners
Galecto Biotech Syndicate Room
Genentech Partnering Talentmark
GIC Talix Therapeutics
Gilde Healthcare Tassi & Co.
GIMV TAXIS Pharmaceuticals, Inc.
GJE LLP The Capital Partnership
Glide Technologies the Side by Side Partnership
Global Core Medical The University of Manchester Intellectual Property Ltd (UMIP)
Goldman Sachs Topas Therapeutics GmbH
Goodwin Proctor Touchstone Innovations
Graphite Capital TPBioVentures Ltd
GSK Trinity Delta
Hadasit Medical Research Services and Development Tusk Therapeutics
Hadean Ventures TVM Capital Life Science
Haemair TYG-Oncology
Hansa Medical AB UCB Pharma
Harbert Management UCB Ventures
Haseltine Lake Universitat Autònoma de Barcelona 
Health Equity Consulting University of Cambridge
Health Ventures University of Dundee 
HealthCap University of Edinburgh
Heat Biologics University of Manchester
Heptares Therapeutics Ventac Partners
Herantis Venture Founders
Hermes Partners Verona Pharma
Hi-Tech Gruenderfunds Vinge
Hookipa Biotech Vita
Horizon Discovery Group Plc VIVET Therapeutics
Idogen AB VolitionDx
Ignite Capital Partners, Inc. Waimangu Ventures
Illumina Ventures Wharton Alumni Angel Network
Image Analysis Group (IAG) Wharton Asset Management
Immersive Rehab White & Case
Immunicum Wren Capital
Imperial Innovations ZOLL Medical, an Asahi Kasei Group Company
Inceptua S.A. Zonda Partners
Independent Investor Zukunftsfonds Heilbronn